MDT

88.48

+1.88%↑

120.48

+4.67%↑

VEEV

159.5

+2.37%↑

HQY

80.5

+3.11%↑

TLRY

6.99

+8.37%↑

MDT

88.48

+1.88%↑

120.48

+4.67%↑

VEEV

159.5

+2.37%↑

HQY

80.5

+3.11%↑

TLRY

6.99

+8.37%↑

MDT

88.48

+1.88%↑

120.48

+4.67%↑

VEEV

159.5

+2.37%↑

HQY

80.5

+3.11%↑

TLRY

6.99

+8.37%↑

MDT

88.48

+1.88%↑

120.48

+4.67%↑

VEEV

159.5

+2.37%↑

HQY

80.5

+3.11%↑

TLRY

6.99

+8.37%↑

MDT

88.48

+1.88%↑

120.48

+4.67%↑

VEEV

159.5

+2.37%↑

HQY

80.5

+3.11%↑

TLRY

6.99

+8.37%↑

Home・Elenco Azioni・Treace Medical Concepts Inc

Treace Medical Concepts Inc

Aperta

2.05 3.54

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

1.94

Massimo

2.05

Metriche Chiave
By Trading Economics
Entrata	6.9M -9.4M
Vendite	12M 63M
Margine di Profitto	-15.026
Dipendenti	450
EBITDA	7M -5.2M

Raccomandazioni
By TipRanks
Raccomandazioni	Neutrale
Previsioni per 12 mesi	+102.99% upside

Dividendi
By Dow Jones
Utili prossimi	7 mag 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-35M 93M
Apertura precedente	-1.49
Chiusura precedente	2.05

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

7.16 / 7.65 Supporto e resistenza

Treace Medical Concepts Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

13 apr 2026, 23:25 UTC

Principali Notizie su Eventi

Westpac Expects Higher Loan Losses as Iran Conflict Slows Australian Economy -- Update

13 apr 2026, 22:45 UTC

Principali Notizie su Eventi

Westpac Expects Higher Loan Losses as Iran Conflict Slows Australian Economy

13 apr 2026, 18:03 UTC

Utili

Louis Vuitton Owner Logs Weak Sales as Middle East War Takes Toll -- 2nd Update

13 apr 2026, 23:58 UTC

Utili

Review & Preview: Earnings Time -- Barrons.com

13 apr 2026, 23:49 UTC

Discorsi di Mercato

Nikkei May Rise After Overnight Gains on Wall Street -- Market Talk

13 apr 2026, 23:33 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Gold Edges Higher Amid Dollar Weakness -- Market Talk

13 apr 2026, 23:20 UTC

Discorsi di Mercato

Uranium Stocks Seen Benefiting From Energy Security Concerns -- Market Talk

13 apr 2026, 23:01 UTC

Utili

Aura: Capex Guidance Revised From $111M and $130M to New Range of $262M and $314M >AURA33.SA.BR

13 apr 2026, 23:01 UTC

Utili

Aura Minerals: Announces Update to Capex Guidance Including Construction of the Era Dorada Project

13 apr 2026, 23:01 UTC

Utili

Aura: Will Update Cap Expenditure Guidance to Include the Project's Construction Phase >AURA33.SA.BR

13 apr 2026, 22:21 UTC

Acquisizioni, Fusioni, Takeovers

Chevron Swaps Offshore Gas Stakes to Boost Venezuelan Heavy-Oil Footprint -- Update

13 apr 2026, 21:53 UTC

Utili

MarketWise, Inc.: Affirms FY 2026 Guidance, Including Div Target to Class A Hldrs of $1.80 per Shr

13 apr 2026, 21:53 UTC

Utili

MarketWise, Inc.: Paid Subscribers Were 381,000 at March 31 Compared to 374,000 at Dec 31, 2025, Active Free Subscribers Were 2.0M at March 31 >MKTW

13 apr 2026, 21:53 UTC

Utili

MarketWise, Inc.: 1Q Billings Increased Approximately 15% Yr-over-Yr to Approximately $81M

13 apr 2026, 21:53 UTC

Utili

MarketWise, Inc.: Preliminary Selected Unaudited 1Q Paid Subscribers Returning to Growth

13 apr 2026, 21:26 UTC

Principali Notizie su Eventi

U.S. Oil Blockade Is Set to Boost American Exports -- and Prices at the Pump -- WSJ

13 apr 2026, 21:23 UTC

Utili

Johnson & Johnson Earnings: Oncology Powers Growth, but Talc Lawsuits Persist -- Barrons.com

13 apr 2026, 21:16 UTC

Utili

Goldman Sachs Reports Record Quarter in Banking and Trading -- 4th Update

13 apr 2026, 20:50 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Basic Materials Roundup: Market Talk

13 apr 2026, 20:50 UTC

Discorsi di Mercato

Auto & Transport Roundup: Market Talk

13 apr 2026, 20:34 UTC

Utili

Victory Capital: 1Q Long-Term AUM Net Flows of -$457M >VCTR

13 apr 2026, 20:34 UTC

Utili

Victory Capital: March Avg Total AUM Was $315.3B, Avg Other Assets $3.2B, Avg Total Client Assets $318.5B >VCTR

13 apr 2026, 20:34 UTC

Utili

Victory Capital Holdings, Inc.: Total Assets Under Management of $309.8B, Other Assets $3.3B, Total Client Assets of $313.1B as of March 31 >VCTR

13 apr 2026, 19:59 UTC

Discorsi di Mercato

Canada Consumers Sour Prior to Big Energy-Price Jump -- Market Talk

13 apr 2026, 19:50 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Oil Futures Pull Back From Highs on Hopes for Talks -- Market Talk

13 apr 2026, 19:27 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Correction to Precious Metals Market Talk on April 9

13 apr 2026, 19:14 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Settle Lower on Mild Weather -- Market Talk

13 apr 2026, 18:59 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Fed's Goolsbee: Don't Be Surprised If Consumer Confidence Sours -- Market Talk

13 apr 2026, 18:59 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Fed's Goolsbee: Oil Shows People Expect Short Term Conflict in Iran -- Market Talk

13 apr 2026, 18:43 UTC

Discorsi di Mercato

Precious Metals Lose Ground as U.S. Blockade in Hormuz Gets Underway -- Market Talk

Confronto tra pari

Modifica del prezzo

Treace Medical Concepts Inc Previsione

Obiettivo di Prezzo

By TipRanks

102.99% in crescita

Previsioni per 12 mesi

Media 4.08 USD 102.99%

Alto 7 USD

Basso 2.25 USD

Basato su 4 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Treace Medical Concepts Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

4 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 4 che hanno fornito valutazioni azionarie a Treace Medical Concepts Inc - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

7.16 / 7.65Supporto e resistenza

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

There is one bullish event.

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Treace Medical Concepts Inc

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.